Anna Shadman

Statistics

Publications

Citations

504

H-Index

Active since

1995

Affiliations

University of California San Diego(Current)

Janssen (Belgium)

University of California San Francisco Medical Center

Anna Shadman is an author at University of California San Diego specializing in antiviral pharmacology, antiviral pharmacotherapy, and antiviral therapy.

Publications per year

1995–2016

Publications

Oral Ganciclovir as Maintenance Treatment for Cytomegalovirus Retinitis in Patients with AIDS

William Drew, David Ives, Jacob Lalezari et al. · New England Journal of Medicine · 1995 · 287 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +17

Pharmacokinetic, Safety, and Antiviral Profiles of Oral Ganciclovir in Persons Infected with Human Immunodeficiency Virus: A Phase I/II Study

Stephen A. Spector, David F. Busch, Stephen Follansbee et al. · The Journal of Infectious Diseases · 1995 · 106 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Cytomegalovirus (CMV) Resistance in Patients with CMV Retinitis and AIDS Treated with Oral or Intravenous Ganciclovir

William Drew, Mary Jean Stempien, J. Andrews et al. · The Journal of Infectious Diseases · 1999 · 46 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer’s disease

Mark Brody, Enchi Liu, Jianing Di et al. · Journal of Alzheimer s Disease · 2016 · 30 citations

Medicine, Neurology, Pharmacology +17

A RANDOMIZED, DOUBLE-BLIND, PHASE 2 STUDY OF THE EFFECTS OF THE VACCINE VANUTIDE CRIDIFICAR WITH QS-21 ADJUVANT ON IMMUNOGENICITY, SAFETY AND AMYLOID IMAGING IN PATIENTS WITH MILD TO MODERATE ALZHEIMER’S DISEASE

Nzeera Ketter, E Liu, Lawrence S. Honig et al. · The Journal of Prevention of Alzheimer s Disease · 2016 · 25 citations

Medicine, Neurology, Neuroscience +14

1–5 of 6